{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:03:26Z","timestamp":1763535806511,"version":"3.40.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuroendocrine tumors (NETs) are rare tumors harboring overexpression of somatostatin receptors (SSTRs) on their cell membrane. Because some organs, such as the spleen, adrenal glands and liver, physiologically express SSTR, it might be challenging to distinguish some pancreatic NETs located in the pancreatic tail from the accessory spleen next to the splenic hilum. In this manuscript, we report a case with hypoglycemia attack and 2 different masses displayed by Gallium 68-tetraazacyclododecane tetraacetic acid-octreotate (<jats:sup>68<\/jats:sup>Ga-DOTATATE) positron emission tomography\/computed tomography (PET\/CT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 63-year-old woman presented to the hospital with confusion and profuse sweating. Biochemical diagnosis of insulinoma was established. <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT revealed two masses with increased tracer uptake located adjacent to the splenic hilum and inferior pole of the spleen which were initially reported as two separate accessory spleens. Then, <jats:sup>99m<\/jats:sup>Tc-labelled heat-denaturated red blood cell (<jats:sup>99m<\/jats:sup>Tc-HDRBC) scintigraphy-single-photon emission computed tomography (SPECT)\/CT was performed to distinguish a NET in the pancreatic tail from accessory spleen at the splenic hilum. Enhanced tracer uptake remained in the inferior pole of spleen, but not in the splenic hilum. The lesions were suggestive of insulinoma in the pancreatic tail and an accessory spleen adjacent to the inferior pole of the spleen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Approximately 10% of the population have an accessory spleen which can show similar imaging characteristics with pancreatic NETs, especially if located in the pancreatic tail. In our presented case, <jats:sup>99m<\/jats:sup>Tc-HDRBC scintigraphy-SPECT\/CT is a useful nuclear medicine method to differentiate a NET in the pancreatic tail from accessory spleen at the splenic hilum which may avoid unnecessary surgeries in the presence of enhanced tracer uptake or vice versa.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-020-00671-9","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T17:03:50Z","timestamp":1610039030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Differentiation of insulinoma from accessory spleen by 99mTc-labelled heat-denaturated red blood cell scintigraphy: case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-6106","authenticated-orcid":false,"given":"Emre","family":"Gezer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berrin","family":"\u00c7etinarslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Karakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Cant\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Selek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"S\u00f6zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"\u0130\u015fg\u00f6ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"671_CR1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","volume":"19","author":"B Oronsky","year":"2017","unstructured":"Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia (United States). 2017;19:991\u20131002.","journal-title":"Neoplasia (United States)"},{"key":"671_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","volume":"19","author":"T Okabayashi","year":"2013","unstructured":"Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19:829\u201337.","journal-title":"World J Gastroenterol"},{"key":"671_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0025-6196(12)62083-7","volume":"66","author":"MM Mcmahon","year":"1991","unstructured":"Service FJ, Mcmahon MM, O\u2019brien PC, Ballard DJ. Functioning Insulinoma\u2014incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66:711\u20139.","journal-title":"Mayo Clin Proc"},{"key":"671_CR4","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","volume":"37","author":"I Virgolini","year":"2010","unstructured":"Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, et al. Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA- conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37:2004\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"671_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00259-011-1935-5","volume":"39","author":"NF Schreiter","year":"2012","unstructured":"Schreiter NF, Brenner W, Nogami M, Buchert R, Huppertz A, Pape UF, et al. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET\/CT for staging enteropancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2012;39:72\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"671_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00259-011-1760-x","volume":"38","author":"C Boy","year":"2011","unstructured":"Boy C, Heusner TA, Poeppel TD, Redmann-Bischofs A, Unger N, Jentzen W, et al. 68Ga-DOTATOC PET\/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUV max. Eur J Nucl Med Mol Imaging. 2011;38:1224\u201336.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"671_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/ajcp\/32.2.165","volume":"32","author":"B Halpert","year":"1959","unstructured":"Halpert B, Gyorkey F. Lesions observed in accessory spleens of 311 patients. Am J Clin Pathol. 1959;32:165\u20138.","journal-title":"Am J Clin Pathol"},{"key":"671_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1385\/IJGC:25:1:65","volume":"25","author":"JM L\u00e4uffer","year":"1999","unstructured":"L\u00e4uffer JM, Baer HU, Maurer CA, Wagner M, Zimmermann A, B\u00fcchler MW. Intrapancreatic accessory spleen: a rare cause of a pancreatic mass. Int J Pancreatol. 1999;25:65\u20138.","journal-title":"Int J Pancreatol"},{"key":"671_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0001-2998(85)80004-0","volume":"15","author":"RR Armas","year":"1985","unstructured":"Armas RR. Clinical studies with spleen-specific radiolabeled agents. Semin Nucl Med. 1985;15:260\u201375.","journal-title":"Semin Nucl Med"},{"key":"671_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/1754-9485.12464","volume":"60","author":"C Werner","year":"2016","unstructured":"Werner C, Winkens T, Freesmeyer M. Splenic scintigraphy for further differentiation of unclear 68Ga-DOTATOC-PET\/CT findings: strengths and limitations. J Med Imaging Radiat Oncol. 2016;60:365\u20139.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"671_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/00003072-199607000-00005","volume":"21","author":"R Sharma","year":"1996","unstructured":"Sharma R, Mondal A, Kashyap R, Chakravarty SK, Sawroop K, Singh T. Radiolabeled denatured RBC scintigraphy in autologous splenic transplantation. Clin Nucl Med. 1996;21:534\u20136.","journal-title":"Clin Nucl Med"},{"key":"671_CR12","first-page":"2286","volume":"32","author":"MD Massey","year":"1991","unstructured":"Massey MD, Stevens JS. Residual spleen found on denatured red blood cell scan following negative colloid scans. J Nucl Med. 1991;32:2286\u20137.","journal-title":"J Nucl Med"},{"key":"671_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0001-2998(84)80022-7","volume":"14","author":"SC Srivastava","year":"1984","unstructured":"Srivastava SC, Rao CL. Radionuclide-labeled red blood cells: current status and future prospects. Semin Nucl Med. 1984;14:68\u201382.","journal-title":"Semin Nucl Med"},{"key":"671_CR14","first-page":"53","volume":"36","author":"J Serrano-Vicente","year":"2017","unstructured":"Serrano-Vicente J, Infante-Torre JR, Garc\u00eda-Bernardo L, Moreno-Caballero M, Mart\u00ednez-Esteve A, Rayo-Madrid JI. Bazo accesorio intrapancre\u00e1tico. Falso positivo con 99mTc-Octreotide. Rev Esp Med Nucl Imagen Mol. 2017;36:53\u20135.","journal-title":"Rev Esp Med Nucl Imagen Mol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00671-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-020-00671-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00671-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T17:36:18Z","timestamp":1610040978000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-020-00671-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["671"],"URL":"https:\/\/doi.org\/10.1186\/s12902-020-00671-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"type":"electronic","value":"1472-6823"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"28 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written consent was signed by the patient for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest whatsoever arising out of the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}